SB 418, sponsored by Sen. MacDonald and SB 417 sponsored by Sen. Peter Lucido act in coalescence with one another to ensure local law enforcement agencies and first responders hold access to Epinephrine lifesaving drugs | Stock Photo
SB 418, sponsored by Sen. MacDonald and SB 417 sponsored by Sen. Peter Lucido act in coalescence with one another to ensure local law enforcement agencies and first responders hold access to Epinephrine lifesaving drugs | Stock Photo
Last month, the Senate Health Policy and Human Services Committee approved Senate Bills 417 and 418 to move onto approval by full Senate.
Both bills were referred to the Committee of the Whole on March 10. As of April 21, no further action had been taken on either bill.
“In emergency situations, quick action by first responders can mean the difference between life and death,” Sen. Michael MacDonald (R-Macomb Township) said in a press release. “Our responders are required to use Narcan to save lives from opioid overdoses, but are unfortunately banned from using an EpiPen to help someone experiencing a dangerous allergic reaction. It doesn’t make any sense.”
SB 418, sponsored by MacDonald, and SB 417, sponsored by Sen. Peter Lucido (R-Shelby Township), act in coalescence with one another to ensure local law enforcement agencies and first responders hold access to epinephrine. SB 417 dictates that law enforcement agencies would be provided access to purchasing and distributing these drugs. SB 418 dictates that first responders and law enforcement police would uphold the right to use these drugs in emergency situations.
Alerts Sign-up